Interleukin Genetics' founder returns to CEO slot

Interleukin Genetics says CEO Lewis Bender has resigned to pursue "other business opportunities." Mass High Tech reports that founder Kenneth Kornman, who is currently president and chief scientific officer, will take the CEO slot, too. Bender started running the company back in 2008 and it has struggled, as the article notes, as sales for genetic tests have plunged. There may not be enough time left for Interleukin, which said it had about $3.8 million in cash and equivalents on hand, to last through November 30. A longer future is possible, the company said, if it can get a credit facility extended. Interleukin develops genetic tests for chronic conditions. Story

Suggested Articles

The former Fierce 15 winner’s SuperMap program was cleared to guide electrophysiologists in the treatment of stable and transient arrhythmias.

Insulet announced new agreements with Abbott and Dexcom to connect their continuous glucose monitors with its upcoming tubeless, digital insulin pump,

In an SEC filing, Baxter International disclosed that it may have overstated its income over multiple years, inflating it by about $276 million.